Cancer News and Research

Latest Cancer News and Research

Afraxis to participate in NIH's Therapeutics for Rare and Neglected Disease Program

Afraxis, a San Diego-based biotechnology company developing drugs to treat rare genetic diseases through the modulation of p21-activated kinase (PAK), announced today that it has been selected to participate in the National Institutes of Health's (NIH) Therapeutics for Rare and Neglected Disease (TRND) Program.

27 Sep 2011

Lead compound activates infection-fighting REDD1 protein and kills flu strain

A compound tested by UT Southwestern Medical Center investigators destroys several viruses, including the deadly Spanish flu that killed an estimated 30 million people in the worldwide pandemic of 1918.

27 Sep 2011

Scientists uncover how methylation changes can influence blood stem cell's fate

Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of Southern California (USC) have uncovered intriguing new evidence helping to explain one of the ways in which a stem cell's fate can be determined.

27 Sep 2011

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

Banner MD Anderson Cancer Center, a unique collaboration between Banner Health and The University of Texas MD Anderson Cancer Center, opens today, ushering in a new era of unprecedented cancer care in Arizona.

27 Sep 2011

ISRA sponsors 'Susan G. Komen Shoot for the Cure' event

In observance of National Breast Cancer Awareness Month, the ISRA is pleased to announce its sponsorship of the first annual "Susan G. Komen Shoot for the Cure" benefit shooting event.

27 Sep 2011

$Women ages 65-69 with hip fracture more likely to die within a year$

Women ages 65-69 with hip fracture more likely to die within a year

Women ages 65-69 who break a hip are five times more likely to die within a year than women of the same age who don't break a hip, according to a Kaiser Permanente Center for Health Research study funded by the National Institutes of Health and published online today in the Archives of Internal Medicine.

27 Sep 2011

Researchers identify frequent SF3B1 gene mutation in myelodysplasia

A genomic study of chronic blood cancer - a precursor to leukaemia - has discovered gene mutations that could enable diagnosis using only a blood test, avoiding the need for an invasive and painful bone marrow biopsy.

27 Sep 2011

Asuragen announces data from Signature LTx v2.0 clinical study on leukemia

Asuragen, Inc. announced today that data from a study evaluating its Signature LTx v2.0, a CE-marked IVD test, for the multiplex detection of fusion transcripts associated with ALL, AML and CML leukemia, will be presented at the upcoming Planet XMAP Europe being held September 28 - 29, 2011 in Vienna, Austria.

27 Sep 2011

Weill Cornell receives NIH's T-R01 Award for spina bifida research

The National Institutes of Health (NIH) has awarded a five-year, $5.5 million Transformative Research Project (T-R01) Award to fund research into risk factors for spina bifida and related congenital defects in which an area of the affected baby's spine or brain is not fully enclosed.

27 Sep 2011

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Ipsen announces today a partnership with Photocure, a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology.

27 Sep 2011

Researchers modify HIV in a way that makes it no longer able to suppress immune system

Researchers at Johns Hopkins have modified HIV in a way that makes it no longer able to suppress the immune system. Their work, they say in a report published online September 19 in the journal Blood, could remove a major hurdle in HIV vaccine development and lead to new treatments.

27 Sep 2011

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Research in Switzerland could help reduce the time taken to develop vaccines against cancer tumours.

27 Sep 2011

Eating blueberries may inhibit breast cancer tumor growth

Eating blueberries may inhibit breast cancer tumor growth, according to a recent study by researchers at the City of Hope in Los Angeles that is published in the October 2011 issue of The Journal Of Nutrition and featured in the September issue of Food Nutrition & Science.

27 Sep 2011

Data from YM BioSciences' nimotuzumab clinical trials to be reported at ECCO-ESMO 2011

YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today announced that data from several clinical trials of nimotuzumab are scheduled be reported at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

27 Sep 2011

No link between chemotherapy during pregnancy and children's cognitive development

Children born after their mothers were treated with chemotherapy during pregnancy appear to be unaffected by the experience in terms of the development of their mental processes and the normal functioning of their hearts, according to new research presented at the 2011 European Multidisciplinary Cancer Congress.

27 Sep 2011

Zoledronic acid may extend survival in older breast cancer patients

A drug used to protect bone may extend survival in older breast cancer patients, according to researchers at the Universities of Sheffield and Leeds.

27 Sep 2011

Synta announces results of ganetespib, docetaxel Phase 1 combination study on solid tumors

Synta Pharmaceuticals Corp. announced that results of a Phase 1 study of ganetespib in combination with docetaxel in solid tumors were presented at the Annual Meeting of the European Society of Medical Oncology in Stockholm, Sweden.

27 Sep 2011

Viewpoints: LA Times wants solutions from GOP candidates; WSJ finds worrisome census numbers

We've now seen three full-dress debates among the Republican politicians who want to be the next president of the United States, and here's what we've learned: They all believe taxes are too high, even though federal taxes are lower as a percentage of the U.S. economy than any time in the last 60 years. They all believe onerous environmental regulations are preventing economic recovery, though few economists would agree.

27 Sep 2011

Researchers discover cell receptor for CDT toxin of C. difficile bacterium

A research group led by Freiburg pharmacologist Prof. Dr. Klaus Aktories and their American colleagues have discovered the cell receptor for the toxin CDT of the bacterium Clostridium difficile.

27 Sep 2011

Men over 75 with prostate cancer are being undertreated: Study

It's an ongoing debate: Should men over a certain age be treated for prostate cancer? Should these patients be submitted to treatments that may result in significant side effects if they may not live very much longer?

27 Sep 2011

Cancer News and Research

Latest Cancer News and Research

Afraxis to participate in NIH's Therapeutics for Rare and Neglected Disease Program

Lead compound activates infection-fighting REDD1 protein and kills flu strain

Scientists uncover how methylation changes can influence blood stem cell's fate

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

ISRA sponsors 'Susan G. Komen Shoot for the Cure' event

Women ages 65-69 with hip fracture more likely to die within a year

Researchers identify frequent SF3B1 gene mutation in myelodysplasia

Asuragen announces data from Signature LTx v2.0 clinical study on leukemia

Weill Cornell receives NIH's T-R01 Award for spina bifida research

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Researchers modify HIV in a way that makes it no longer able to suppress immune system

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Eating blueberries may inhibit breast cancer tumor growth

Data from YM BioSciences' nimotuzumab clinical trials to be reported at ECCO-ESMO 2011

No link between chemotherapy during pregnancy and children's cognitive development

Zoledronic acid may extend survival in older breast cancer patients

Synta announces results of ganetespib, docetaxel Phase 1 combination study on solid tumors

Viewpoints: LA Times wants solutions from GOP candidates; WSJ finds worrisome census numbers

Researchers discover cell receptor for CDT toxin of C. difficile bacterium

Men over 75 with prostate cancer are being undertreated: Study

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in